6i74 Citations

Substituted polyfluoroaryl interactions with an arginine side chain in galectin-3 are governed by steric-, desolvation and electronic conjugation effects.

Org Biomol Chem 17 1081-1089 (2019)
Related entries: 6i75, 6i76, 6i77, 6i78

Cited: 8 times
EuropePMC logo PMID: 30632578

Abstract

In the β-d-galactopyranoside-binding protein galectin-3, synthetic inhibitors substituted at the 3-position of a thiodigalactoside core cause the formation of an aglycone binding pocket through the displacement of an arginine residue (Arg144) from its position in the apoprotein. To examine in detail the role of different molecular interactions in this pocket, we have synthesized a series of nine 3-(4-(2,3,5,6-tetrafluorophenyl)-1,2,3-triazol-1-yl)-thiogalactosides with different para substituents and measured their affinities to galectin-3 using a fluorescence polarization assay. High-resolution crystal structures (<1.3 Å) have been determined for five of the ligands in complex with the C-terminal domain of galectin-3. The binding affinities are rationalised with the help of the three-dimensional structures and quantum-mechanical calculations. Three effects seem to be involved: Firstly, the binding pocket is too small for the largest ligands with ethyl and methyl. Secondly, for the other ligands, the affinity seems to be determined mainly by desolvation effects, disfavouring the polar substituents, but this is partly counteracted by the cation-π interaction with Arg144, which stacks on top of the substituted tetrafluorophenyl group in all complexes. The results provide detailed insight into interactions of fluorinated phenyl moieties with arginine-containing protein binding sites and the complex interplay of different energetic components in defining the binding affinity.

Articles - 6i74 mentioned but not cited (3)

  1. Aminopyrimidine-galactose hybrids are highly selective galectin-3 inhibitors. Dahlqvist A, Zetterberg FR, Leffler H, Nilsson UJ. Medchemcomm 10 913-925 (2019)
  2. Computational Study of Potential Galectin-3 Inhibitors in the Treatment of COVID-19. Aminpour M, Cannariato M, Zucco A, Di Gregorio E, Israel S, Perioli A, Tucci D, Rossi F, Pionato S, Marino S, Deriu MA, Velpula KK, Tuszynski JA. Biomedicines 9 1208 (2021)
  3. The oxygen-oxygen distance of water in crystallographic data sets. Palese LL. Data Brief 28 105076 (2020)


Articles citing this publication (5)

  1. Understanding the role of galectin inhibitors as potential candidates for SARS-CoV-2 spike protein: in silico studies. Sethi A, Sanam S, Munagalasetty S, Jayanthi S, Alvala M. RSC Adv 10 29873-29884 (2020)
  2. 3-Substituted 1-Naphthamidomethyl-C-galactosyls Interact with Two Unique Sub-sites for High-Affinity and High-Selectivity Inhibition of Galectin-3. Dahlqvist A, Mandal S, Peterson K, Håkansson M, Logan DT, Zetterberg FR, Leffler H, Nilsson UJ. Molecules 24 E4554 (2019)
  3. Exploring ligand dynamics in protein crystal structures with ensemble refinement. Caldararu O, Ekberg V, Logan DT, Oksanen E, Ryde U. Acta Crystallogr D Struct Biol 77 1099-1115 (2021)
  4. Molecular dynamics simulations elucidate oligosaccharide recognition pathways by galectin-3 at atomic resolution. Koneru JK, Sinha S, Mondal J. J Biol Chem 297 101271 (2021)
  5. Optimized Ebselen-Based Inhibitors of Bacterial Ureases with Nontypical Mode of Action. Macegoniuk K, Tabor W, Mazzei L, Cianci M, Giurg M, Olech K, Burda-Grabowska M, Kaleta R, Grabowiecka A, Mucha A, Ciurli S, Berlicki Ł. J Med Chem 66 2054-2063 (2023)